Francesca Civoli, as the Founder and Principal of Francesca Civoli Consulting, LLC, brings over 25 years of extensive experience in the pharmaceutical and biotechnology industries, specializing in the development of both biosimilar and innovator drug candidates. Her deep expertise in immuno-oncology has positioned her as...
Francesca Civoli, as the Founder and Principal of Francesca Civoli Consulting, LLC, brings over 25 years of extensive experience in the pharmaceutical and biotechnology industries, specializing in the development of both biosimilar and innovator drug candidates. Her deep expertise in immuno-oncology has positioned her as a thought leader in the field, where she leverages her strong strategic approach to bioanalytical assessments, particularly in immunogenicity and pharmacokinetics (PK). Francesca's ability to interpret and present complex data has been instrumental in achieving several regulatory approvals for novel therapeutics, underscoring her significant contributions to advancing drug development.
At Francesca Civoli Consulting, LLC, she provides invaluable insights into non-clinical and clinical drug development, focusing on critical areas such as immunogenicity, PK, biomarkers, and companion diagnostics (CDx). Her extensive experience encompasses the development of both biosimilar and originator biologic products, allowing her to navigate the intricate regulatory landscape with confidence. Francesca’s proficiency in bioanalysis, laboratory automation, and cell-based assays enables her to deliver tailored solutions that meet the unique challenges faced by her clients.
In addition to her technical acumen, Francesca excels in CRO management and has honed her presentation skills to effectively communicate complex scientific concepts to diverse audiences. Her commitment to advancing biomedical sciences and biopharmaceuticals is evident in her collaborative approach, where she partners with organizations to drive innovation and ensure successful product development. Through her consultancy, Francesca Civoli continues to shape the future of drug development, making a lasting impact on the industry.
